A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia
Clinical trial NCT03338426 · COMPLETED
Trial details
- NCT number
- NCT03338426
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-15
- Primary completion
- 2019-04-22
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.